Enhancing the quality of life of cancer patients through the development of efficacious and well-tolerated drugs stand behind every activity undertaken at Lorus. Our commitment to our shareholders is a life long commitment, one that ensures we deliver products with the potential to be used alone or in combination chemotherapy to manage cancer. Our capable and experienced team of professionals remains focused on this mission